- Home
- SCNX vs TURN Comparison
SCNX vs TURN Comparison
Compare SCNX & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNX
- TURN
- Stock Information
- Founded
- SCNX 2010
- TURN 1981
- Country
- SCNX United States
- TURN United States
- Employees
- SCNX N/A
- TURN N/A
- Industry
- SCNX Other Pharmaceuticals
- TURN Finance/Investors Services
- Sector
- SCNX Health Care
- TURN Finance
- Exchange
- SCNX Nasdaq
- TURN Nasdaq
- Market Cap
- SCNX 33.6M
- TURN 39.6M
- IPO Year
- SCNX 2020
- TURN N/A
- Fundamental
- Price
- SCNX $1.24
- TURN $3.72
- Analyst Decision
- SCNX
- TURN
- Analyst Count
- SCNX 0
- TURN 0
- Target Price
- SCNX N/A
- TURN N/A
- AVG Volume (30 Days)
- SCNX 2.8M
- TURN 38.0K
- Earning Date
- SCNX 05-10-2025
- TURN 05-12-2025
- Dividend Yield
- SCNX N/A
- TURN N/A
- EPS Growth
- SCNX N/A
- TURN N/A
- EPS
- SCNX 3.55
- TURN N/A
- Revenue
- SCNX N/A
- TURN $194,813.00
- Revenue This Year
- SCNX $1,085.75
- TURN N/A
- Revenue Next Year
- SCNX N/A
- TURN N/A
- P/E Ratio
- SCNX $0.53
- TURN N/A
- Revenue Growth
- SCNX 166.67
- TURN 254.25
- 52 Week Low
- SCNX $1.00
- TURN $3.12
- 52 Week High
- SCNX $30.05
- TURN $4.40
- Technical
- Relative Strength Index (RSI)
- SCNX N/A
- TURN 36.71
- Support Level
- SCNX N/A
- TURN $3.67
- Resistance Level
- SCNX N/A
- TURN $3.90
- Average True Range (ATR)
- SCNX 0.00
- TURN 0.11
- MACD
- SCNX 0.00
- TURN -0.03
- Stochastic Oscillator
- SCNX 0.00
- TURN 28.26
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.